CabotSTU:CBT +0.18%73 EBITDA Margin % is 20.69% as of Mar. 2026, which is 21% above its 10-year median of 17.14. GuruFocus rates STU:CBT with a GF Score™ of 73/100 and a GF Value™ of €65.22 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 1,585 Chemicals companies, Cabot ranks better than 84.92% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Cabot's EBITDA for the
three
months ended in Mar. 2026 was €162 Mil. Cabot's Revenue for the
three
months ended in Mar. 2026 was €782 Mil. Therefore, Cabot's EBITDA margin for the quarter that ended in Mar. 2026 was 20.69%.
Cabot (STU:CBT) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Cabot EBITDA Margin % Related Terms
Cabot EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Cabot's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:CBT vs SXT, BCPC, PRM: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Cabot's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cabot EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Cabot's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Cabot's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cabot (STU:CBT) has a EBITDA Margin % of 20.69% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Cabot and its competitors. This is 21% above median its historical median of 17.14. Over the past decade, Cabot's EBITDA Margin % has ranged from 6.81 to 21.41. According to the industry distribution chart, Cabot ranks #239 out of 1585 companies in the Chemicals industry, placing it in the top 15.1%.
Is Cabot's EBITDA Margin % too high?
Cabot's current EBITDA Margin % of 20.69% is 21% above median its 10-year median of 17.14. Over the past 10 years, this metric has ranged from a low of 6.81 to a high of 21.41. The Chemicals industry median EBITDA Margin % is 9.63. Cabot's value of 20.69% is 114.8% above this industry median. Based on the distribution chart, Cabot ranks #239 out of 1585 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Cabot has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cabot's EBITDA Margin % compare to SXT and BCPC?
According to the Chemicals industry distribution chart, Cabot ranks #239 out of 1585 companies for EBITDA Margin %. This places Cabot in the top 15% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.63. Cabot's value of 20.69% is 114.8% above this benchmark. Historically, Cabot's own EBITDA Margin % has ranged from 6.81 to 21.41 over the past decade. While the company's 10-year median is 17.14 vs. the industry median of 9.63, Cabot has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cabot's current EBITDA Margin % of 20.69% is 114.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Cabot and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cabot's current EBITDA Margin % is 20.69%, which is 21% above median its own 10-year median of 17.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cabot stock overvalued right now?
Based on GuruFocus' analysis, Cabot (STU:CBT) is currently considered Modestly Overvalued. The stock's GF Value™ is €65.22, compared to a current price of €82.00 — trading 25.7% above its estimated fair value. The current EBITDA Margin % is 20.69%, which is 21% above median its 10-year median of 17.14 and 114.8% above the Chemicals industry median of 9.63. Cabot's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Cabot (STU:CBT), the current EBITDA Margin % is 20.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cabot (STU:CBT) Overvalued in 2026?
Based on GuruFocus' analysis, Cabot stock appears to be overvalued.
The current stock price of €82.00 is trading 25.7% above its estimated GF Value™ of €65.22.
GuruFocus considers Cabot to be Modestly Overvalued.
Key valuation signals for STU:CBT:
EBITDA Margin %: 20.69% (21% above median its 10-year median of 17.14)
GF Value™: €65.22 vs. price of €82.00 (25.7% above fair value)
Industry Position: 114.8% above the Chemicals median (#239 of 1585)
No single metric tells the full story. See the STU:CBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
73GF Score
Get the complete analysis for STU:CBT
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:CBT has been successfully added to your 
